Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abivax SA (GB:0RA9)
LSE:0RA9
Abivax SA (0RA9) Share Price & Analysis
0 Followers
0RA9 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€7.92 - €19.58
Previous Close€14.76
Volume3.99K
Average Volume (3M)2.04K
Market Cap
€928.69M
Enterprise Value€732.22M
Total Cash (Recent Filing)€251.94M
Total Debt (Recent Filing)€55.47M
Price to Earnings (P/E)-4.3
Beta1.97
Next Earnings
Sep 09, 2024EPS Estimate
-€1.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.43
Shares OutstandingN/A
10 Day Avg. Volume49
30 Day Avg. Volume2,039
Standard Deviation0.41
R-Squared0.73
Alpha0.22
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€17.50Price Target Upside23.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.02% Mutual Funds
0.31% Other Institutional Investors
99.67% Public Companies and
Individual Investors
0RA9 FAQ
What was Abivax SA’s price range in the past 12 months?
Abivax SA lowest share price was €7.92 and its highest was €19.58 in the past 12 months.
What is Abivax SA’s market cap?
Currently, no data Available
When is Abivax SA’s upcoming earnings report date?
Abivax SA’s upcoming earnings report date is Sep 09, 2024 which is in 129 days.
How were Abivax SA’s earnings last quarter?
Abivax SA released its earnings results on Apr 02, 2024. The company reported -€0.785 earnings per share for the quarter, missing the consensus estimate of -€0.74 by -€0.045.
Is Abivax SA overvalued?
According to Wall Street analysts Abivax SA’s price is currently Undervalued.
Does Abivax SA pay dividends?
Abivax SA does not currently pay dividends.
What is Abivax SA’s EPS estimate?
Abivax SA’s EPS estimate is -€1.55.
How many shares outstanding does Abivax SA have?
Abivax SA has 62,928,818 shares outstanding.
What happened to Abivax SA’s price movement after its last earnings report?
Abivax SA reported an EPS of -€0.785 in its last earnings report, missing expectations of -€0.74. Following the earnings report the stock price went up 0.149%.
Which hedge fund is a major shareholder of Abivax SA?
Currently, no hedge funds are holding shares in GB:0RA9
---
Abivax SA Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-149.31%
Trailing 12-Months
Asset Growth
345.88%
Trailing 12-Months
Company Description
Abivax SA
Abivax SA is a France based biotechnology company. It is focused on using antiviral technology platform targeting the immune system to eliminate viral diseases. The company's product is ABX 464 which is for treating HIV/AIDS. The antiviral and immunotherapeutic products that the group develops results from three technology platforms; an Antiviral platform, an Immune stimulation platform and a Polyclonal antibody platform. The Antiviral platform targets the formation of Ribonucleoprotein's in the nucleus or the cytoplasm of the infected cell during viral infection, Immune stimulation platform focuses on invariant natural killer agonists and Polyclonal antibodies platform generates neutralizing antibodies against different viruses.
---
0RA9 Stock 12 Months Forecast
Average Price Target
€17.50
▲(23.62% Upside)
Technical Analysis
Best Analysts Covering 0RA9
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+14.59%
reiterated a buy rating 16 days ago
Copying Justine Telliez's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +14.59% per trade.
---